Skip to main content
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. — Investor Relations & Filings

Ticker · EBS ISIN · US29089Q1058 LEI · 549300YW6TUOX8BE5103 US Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2018-05-25 Director's Dealing
Country US United States of America
Listing US EBS

About Emergent BioSolutions Inc.

https://emergentbiosolutions.com/

Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2018-05-25 English
FORM 4
Director's Dealing
2018-05-25 English
FORM 4
Director's Dealing
2018-05-24 English
FORM 4
Director's Dealing
2018-05-24 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated May 24, 2018. It reports on the 2018 annual meeting of stockholders of Emergent BioSolutions Inc., including the approval of a stock incentive plan amendment and the voting results for director elections and other proposals. The content focuses on the submission of matters to a vote of security holders and the results of those votes. There is no detailed financial data or comprehensive report content such as an annual or quarterly report. The document is primarily an announcement of voting results from the annual meeting. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (6341 characters) supports it being a full announcement rather than a brief notice or proxy statement. Confidence is high given the clear content and format.
2018-05-24 English
FORM 4
Director's Dealing
2018-05-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.